Previous close | 22.06 |
Open | 21.57 |
Bid | 22.10 x 52600 |
Ask | 22.52 x 51600 |
Day's range | 21.57 - 21.98 |
52-week range | 17.76 - 33.50 |
Volume | |
Avg. volume | 21 |
Market cap | 940.162M |
Beta (5Y monthly) | 1.72 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.01 |
Earnings date | 02 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 125.20 |
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SEATTLE, April 25, 2024--As the number one most frequently claimed condition among Trupanion pet parents, allergies in pets are a topic of increasing priority for pet parents. With over 20 years of pet health data, Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, has conducted a deep dive into its veterinary invoice data, revealing trends and insights as well as offering some practical tips for pet parents.
SEATTLE, April 22, 2024--Trupanion (Nasdaq: TRUP), the leading provider of pet medical insurance, is proud to announce the launch of truInsights, an initiative designed to deliver valuable health-related data and insights to pet parents. This initiative will provide a series of discussions covering topics relevant to everyday pet health, offering data-driven insights and practical advice to pet parents.